Eugenio Battaglia

Eugenio Battaglia

Oct 17, 2014

Group 6 Copy 234
-1
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Are climate change and air pollution triggering cardiovascular disease?

    Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

    Can albumin from egg whites be used to treat Clostridium difficile infections?

    Clostridium difficile infection is a toxin-mediated bacterial infection responsible for 500,000 infections...

    A Modification to Homeopathic Drug Carcinosin

    Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem...

    Backer Badge Funded